It attributed the improvement to a surge in funding, which rose from 100 million dollars in 2003 to 1.5 billion dollars in 2010, bringing total spending over the decade to some five billion.
"This dramatic rise in funding helped transform the malaria landscape, making universal coverage with proven interventions an achievable goal for many countries," said the report.
Mortality from malaria in 2009 was 781,000, compared with 984,000 in 2000, the Geneva-based RBM agency said in a report.
Mean while, a new research has found that using weakened malaria parasites as the basis of a vaccine represents a potentially encouraging anti-malaria strategy.
Set as favorite
Bookmark
Email this
Hits: 332
Comments (0)
Subscribe to this comment's feed
Write comment
